Meet with us

Where to meet us next?

Optimapharm conference attendance

2024

ESC Congress 2024

Optimapharm at ESC Congress 2024
Optimapharm is delighted to announce its participation in the upcoming ESC Congress, scheduled for August 30th to September 2nd in London, UK. This premier event will gather esteemed experts, researchers, and professionals from the cardiovascular field, offering a unique opportunity to delve into the latest advancements, innovations, and research in cardiovascular science.
If you are attending, we invite you to connect with Danilo Stancetic, Optimapharm’s Business Development Director, to explore how Optimapharm can contribute to your cardiovascular research initiatives. 

ISSCD 2024

ISSCD
Optimapharm will be participating in the 20th International Celiac Disease Symposium (ICDS), scheduled to take place this September in Sheffield, UK. The biennial meeting of the ISSCD for over 40 years ICDS has been the largest global meeting for health professionals, researchers, scientists and others working to promote scientific knowledge, education and quality of care in the field of coeliac disease and gluten-mediated human disease.
Representing Optimapharm at this significant event will be Business Development Director, Poppy Gratton. All attendees are invited to connect with Poppy to discover our innovative approaches and comprehensive solutions for advancing celiac disease research.​

ESMO 2024

Optimapharm attending oncology conference ESMO
The ESMO Congress is a globally influential oncology platform for clinicians, researchers, patient advocates, and healthcare industry representatives from all over the world. ESMO 2024 will be held from 13-17 September in Barcelona, Spain. This congress will disseminate the latest cutting-edge data, provide high quality education and excellent networking opportunities for oncologists and other stakeholders from all around the world.
Our Business Development Director, Sara Babic, will attend ESMO Congress 2024. ​If you are attending, don’t miss the opportunity to connect with us and discuss how we can shape the future of your oncology clinical trials and advance the oncology field!​

OCT Nordics 2024

Optimapharm exhibiting at the OCT Nordics conference
Optimapharm will be exhibiting at the OCT Nordics 2024 conference in Copenhagen on 1 and 2 October. The 12th Annual Outsourcing in Clinical Trials Nordics 2024 is the meeting place for the pharmaceutical, biotechnology, and medical device communities in the Nordics to network and discuss strategies for operational success in clinical trials.
If you are attending, don’t miss the opportunity to meet with our experts, Stiina Vuorio, Executive Director, Clinical Operations, and Danilo Stancetic, Business Development Director, to discuss how we can support your upcoming clinical projects!​ Reach out to us and book a meeting with our team members, or stop by booth #31!​

2024

ESC Congress 2024
30 August – 2 September | London, UK
ISSCD
5-7 September | Sheffield, UK
ESMO 2024
13-17 September | Barcelona, Spain
OCT Nordics
1-2 October | Copenhagen, Denmark
World Orphan Drug Conference
23-25 October | Barcelona, Spain
SCOPE EU
29-30 October | Barcelona, Spain
OCT DACH
12-13 November | Munich, Germany
COG EU
12-13 November | Amsterdam, Netherlands

Schedule a Meeting

Optimapharm is responsible for the processing of the personal data you provide, and inform you that it will be processed in accordance with the provisions of the laws in force related to data protection and notably the General Data Protection Regulation 2016/679. Your data will be used in order to establish or maintain a business relationship and sending you communications about our services. The data will be kept as long as there is a legitimate interest. As a data subject, you will have the right to withdraw your consent at any time. You will also have the right to access, to rectify, to erase your personal data as well as the right to ask for its portability or the limitation of its processing.